BMS-986278，溶血磷脂酸1 (LPA1)受体拮抗剂，健康参与者:单次/多次递增剂量(SAD/MAD) 1期研究

{"title":"BMS-986278，溶血磷脂酸1 (LPA1)受体拮抗剂，健康参与者:单次/多次递增剂量(SAD/MAD) 1期研究","authors":"G. Tirucherai, Dale Yu, Ratna G. Revankar, G. Klinger, J. Lier, J. Taubel, Todd A Correll","doi":"10.1183/13993003.congress-2019.pa1398","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":267660,"journal":{"name":"Rare ILD/DPLD","volume":"150 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: A single/multiple ascending dose (SAD/MAD) phase 1 study\",\"authors\":\"G. Tirucherai, Dale Yu, Ratna G. Revankar, G. Klinger, J. Lier, J. Taubel, Todd A Correll\",\"doi\":\"10.1183/13993003.congress-2019.pa1398\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":267660,\"journal\":{\"name\":\"Rare ILD/DPLD\",\"volume\":\"150 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rare ILD/DPLD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2019.pa1398\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare ILD/DPLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa1398","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}